Health Research

Baroness Blackwood of North Oxford Excerpts

Wednesday 12th February 2025 Lords Chamber

[Baroness Merron (Lab)]

The noble Lord makes an important point. Decisions made by other countries, including the United States, are a matter for them. As the noble Lord said, if this goes ahead—I have made comments on a lawsuit, so I am limited in what I can say—while the US is indeed one of the UK’s closest partners in this area, we will seek every opportunity internationally and continue our commitment to see research at the heart of our NHS into the future.

[Baroness Blackwood of North Oxford (Con)]

My Lords, as my ally the noble Lord, Lord Patel, rightly says, uncertainties in the United States with health funding presents an opportunity for the United Kingdom. The research funded by the MRC alone led to spin-out companies which created value of more than £6.1 billion, 3,800 jobs and £10.2 billion of external investment. Will the Minister and her department commit to campaigning for ongoing research and investment through what will be an uncertain and difficult SR for health and medical research?

[Baroness Merron (Lab)]

As we move towards the 10-year plan, it will be key. Research, the contribution of life sciences and innovation will help us deliver an NHS that is fit for the future. I agree with the noble Baroness about the major contribution that is made to the UK economy. This is not just about healthcare, important though that is; it is also about growth. There are some 6,800 businesses generating more than £100 billion in turnover. Life sciences is one of the most dynamic and significant sectors. It drives economic growth, but it also provides a future in terms of the quality, availability and efficiency of the healthcare that we can provide in this country.